 'High single-dose European PUVA regimen excess non-melanoma skin cancer results long-term years study detection malignant benign skin tumours patients psoriasis PUVA European single-dose regimen total squamous cell carcinomas SCC basal cell carcinomas BCC patients incidence SCC BCC comparison general Dutch population ratio SCC BCC general population study group positive correlation development SCC total UVA dosage age patient start PUVA treatment history arsenic use dose-related increase incidence SCC studies European studies average time period start PUVA therapy diagnosis first malignant tumour years SCC years BCC benign skin tumours actinic keratoses keratoacanthoma 'PUVA keratoses hyperkeratotic lesion PUVA-treated patients